Earnings NewsHealthcareMedexus Pharmaceuticals reports FQ3 resultsMar. 01, 2021 5:16 PM ETMedexus Pharmaceuticals Inc. (MEDXF) Stock, MDP:CA StockBy: Pranav Ghumatkar, SA News Editor Medexus Pharmaceuticals (OTCQX:MEDXF): FQ3 Adj. EBITDA of C$5.1M. Revenue of C$31.5M (+94.4% Y/Y) Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgMEDXFMEDXF--MDP:CAMDP:CA--1D5D1M6M1Y5Y10YCompareTrending AnalysisTrending News